Ads about the opioid crisis are particularly prominent in hard-hit states, such as Ohio and West Virginia. In other news from the epidemic: pain patients push back on new restrictions on medication and businesses are encouraging workers to be up front about their addiction.
from Kaiser Health News https://ift.tt/2OzDFaA
September 19, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Fertility Rate Hits Record Low In What Experts Call One Of ‘Biggest Demographic Mysteries Of Recent Times’“Every year I look at data and expect it will be the year that birthrates start to tick up, and every year we hit another all-time low” in the United States, says Kenneth M. Johnson, a demographer at the University of New Ham… Read More
San Francisco Launches Initiative To Seek Out Drug Users And Offer Anti-Addiction Prescriptions On The StreetMedication-assisted treatment with buprenorphine, methadone and naltrexone is widely considered the most effective way to wean users off opioids, but a major barrier is getting people the treatment. "We can’t wait for addicts… Read More
First Nonopioid Treatment To Ease Withdrawal Symptoms Approved By FDARegulators say that Lucemyra is not an addiction medicine but that it can be part of a longer-term treatment plan. "The physical symptoms of opioid withdrawal can be one of the biggest barriers for patients seeking help and u… Read More
Screening Rates For Lung Cancer ‘Truly Abysmal,’ Study FindsThe rates for other screenings are usually between 60 to 80 percent, while less than 2 percent of patients are taking advantage of lung screenings which can catch cancer while its still curable. from Kaiser Health News https… Read More
Study Shows Breast Cancer Treatment Can Be Cut In Half: There’s No Longer A ‘Need To Throw The Kitchen Sink At It’Typically, Herceptin is used for a year to treat breast cancer patients, but a new study finds it is effective with six months of use. The drug can damage the heart, and so a shorter amount of time taking it can improve patie… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment